Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,041,125
  • Shares Outstanding, K 249,073
  • Annual Sales, $ 65,140 K
  • Annual Income, $ -57,240 K
  • 60-Month Beta 1.89
  • Price/Sales 16.44
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MNKD with:

Options Overview

Details
  • Implied Volatility 93.18%
  • Historical Volatility 85.80%
  • IV Percentile 8%
  • IV Rank 8.42%
  • IV High 409.00% on 09/28/20
  • IV Low 64.15% on 09/30/20
  • Put/Call Vol Ratio 0.26
  • Today's Volume 1,804
  • Volume Avg (30-Day) 3,483
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 95,243
  • Open Int (30-Day) 49,142

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.12 +33.97%
on 03/25/21
4.66 -10.30%
on 04/15/21
+0.31 (+8.01%)
since 03/16/21
3-Month
3.12 +33.97%
on 03/25/21
6.25 -33.12%
on 02/24/21
+1.04 (+33.12%)
since 01/15/21
52-Week
1.14 +266.67%
on 05/14/20
6.25 -33.12%
on 02/24/21
+2.96 (+242.62%)
since 04/16/20

Most Recent Stories

More News
MannKind Announces Closing of Initial Purchasers' Option to Purchase Additional Convertible Senior Notes

MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued an additional $30.0 million aggregate principal amount of 2.50% Convertible Senior Notes due 2026 (the "notes") pursuant...

MNKD : 4.18 (-2.79%)
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors

MannKind Corporation (Nasdaq: MNKD), announced today that it will participate in the 2022 Medicare Part D Senior Savings Model, which is intended to improve the affordability of insulin for Medicare beneficiaries...

MNKD : 4.18 (-2.79%)
MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that...

MNKD : 4.18 (-2.79%)
NASDAQ Drops Another 2.7% as Bond Yields Rise Again

NASDAQ Drops Another 2.7% as Bond Yields Rise Again

SAIL : 49.83 (-0.82%)
MMSI : 61.78 (+0.68%)
RDUS : 19.71 (-0.15%)
TTD : 718.86 (-2.20%)
BJ : 45.20 (+1.12%)
NVAX : 227.35 (+12.50%)
PRIM : 34.90 (+0.35%)
CAR : 79.15 (+1.24%)
MNKD : 4.18 (-2.79%)
ZUMZ : 45.70 (-1.21%)
TVTX : 24.95 (-3.82%)
GH : 158.50 (-0.44%)
VXRT : 5.35 (-1.38%)
QDEL : 128.83 (+2.26%)
PLAN : 60.51 (-3.09%)
NFLX : 546.54 (-0.49%)
AAPL : 134.16 (-0.25%)
AMZN : 3,399.44 (+0.60%)
GOOG : 2,297.76 (+0.05%)
FB : 306.18 (-0.53%)
MSFT : 260.74 (+0.48%)
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that...

MNKD : 4.18 (-2.79%)
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering

MannKind Corporation (Nasdaq: MNKD) today announced the pricing of $200.0 million aggregate principal amount of 2.50% Convertible Senior Notes due 2026 (the "notes") in a private placement (the "offering")...

MNKD : 4.18 (-2.79%)
MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes

MannKind Corporation (NASDAQ:MNKD) today announced that it intends to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of Convertible Senior Notes due 2026...

MNKD : 4.18 (-2.79%)
Vertice launches THYQUIDITY™ (levothyroxine sodium) Oral Solution

, /PRNewswire/ -- Vertice Pharma ("Vertice"), a specialty pharmaceuticals company focused on improving patients' health, today announced the launch of THYQUIDITY. THYQUIDITY is indicated as a replacement...

MNKD : 4.18 (-2.79%)
Stocks Still Near All-Time Highs Despite Sluggish Week

Stocks Still Near All-Time Highs Despite Sluggish Week

NUS : 52.99 (-0.11%)
BBIO : 55.12 (+0.31%)
MCFT : 27.36 (+0.26%)
MNKD : 4.18 (-2.79%)
TVTX : 24.95 (-3.82%)
AIMC : 62.95 (+0.30%)
FISV : 125.09 (-0.35%)
BTG : 5.11 (+2.61%)
AAWW : 66.87 (+1.77%)
MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that...

MNKD : 4.18 (-2.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

3rd Resistance Point 4.48
2nd Resistance Point 4.39
1st Resistance Point 4.29
Last Price 4.18
1st Support Level 4.10
2nd Support Level 4.01
3rd Support Level 3.91

See More

52-Week High 6.25
Fibonacci 61.8% 4.30
Last Price 4.18
Fibonacci 50% 3.69
Fibonacci 38.2% 3.09
52-Week Low 1.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar